Full Breakdown
Mississippi Prison Healthcare Under Scrutiny: Testimony Reveals Delays, Amputations, and Hepatitis C Gaps
By Drooid · · How we work
Core Event – Lawmakers Hear Testimony on Prison Health Failures
In a joint hearing of the Mississippi House and Senate Public Health and Corrections committees, legislators heard more than three hours of testimony about systemic shortcomings in the state prison medical system. The hearing focused on preventable amputations, cancer-treatment delays, and inadequate hepatitis C care. The Mississippi Department of Corrections (MDOC) did not attend, despite a letter urging its officials to appear.
Background & Context
VitalCore Health Strategies, a Kansas-based contractor founded by Lorelei Ammons in 2018, received an emergency, no-bid contract in 2020 after the previous provider’s contract was terminated. The company was awarded over $315 million in emergency contracts from 2020-2024 and a three-year contract worth more than $357 million in 2024. VitalCore’s leadership says staffing shortfalls and legacy issues from the prior contractor contributed to current gaps.
Data & Statistics
- Cancer-screening delays: a prostate-specific antigen of 60 (normal 0-4) was recorded in fall 2025; biopsy occurred in April 2026 and treatment began in August 2026.
- Amputations: multiple inmates experienced lower-leg amputations after uncontrolled diabetes; one case involved a prisoner released to a Motel 6 with both legs already amputated.
- Hepatitis C treatment: VitalCore reports treating 50 diagnosed patients each quarter and projects curing over 700 by 2029. House Corrections Chairwoman Becky Currie cited a conversation with MDOC Commissioner Burl Cain indicating “over 5,000 inmates” have hepatitis C.
Official Statements & Responses
Oncologist Dr. Jacob Graham (South Central Regional Medical Center, Laurel) described “significant delays” in diagnosing and treating incarcerated patients, noting a prostate-cancer case that progressed to spinal-cord paralysis before treatment began. State Health Officer Dr. Dan Edney called the current hepatitis C treatment rate “unacceptable,” emphasizing that universal screening and prompt therapy are essential. VitalCore’s founder and CEO Viola Riggin argued the company inherited a “dire” state of care in 2020 and is now meeting staffing requirements and paying vendors within 90 days.
Criticism & Opposition
Republican Rep. Elliot Burch recounted traveling to a Motel 6 where a former inmate, released after a year of prison care, was found with both legs amputated. Rep. Steve Lott reported a similar case in which a parolee’s leg was amputated three days after release. Pearly White, a veteran and surgical-technician, alleged her son was denied gabapentin, forcing her to purchase illegal drugs through a prison app, leading to debt and reports to MDOC’s Corrections Investigation Division and the FBI.
Conflicting Reports & Gaps
- Hepatitis C numbers: VitalCore’s quarterly treatment figure (50 patients) contrasts sharply with Currie’s statement that “over 5,000 inmates” are infected, suggesting a substantial reporting gap.
- MDOC participation: The department’s absence from the hearing leaves unanswered questions about its oversight role and the reasons for non-attendance, despite multiple legislative requests for explanation.
Verbatim Quotes
- “They have help. The officers, they know.” — Pearly White
- “When I first became chair, when Burl and I actually got along, we had many, many discussions, and he told me that over 5,000 inmates had hep C,” — Becky Currie
- “If you don’t, with a confined population, you will have reinfection,” — Dan Edney
What’s Next
Legislators plan to introduce reforms to tighten oversight of VitalCore’s contracts and improve screening and treatment protocols. Committee chairs have again urged MDOC Commissioner Burl Cain to appear before the joint committee to address the concerns raised during the hearing.